Citations for

1	DDB2, ACP2
	Identification of a Novel Risk Locus for Progressive Supranuclear Palsy by a Pooled Genomewide Scan of 500,288 Single-Nucleotide Polymorphisms.
	Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Litvan I, Farrer MJ, Dickson DW, Hutton M, Stephan DA.
	Am J Hum Genet 80(4):769-778. Epub 2007 Mar 8. 2007
2	ACP2
	The tyrosine motifs of Lamp 1 and LAP determine their direct and indirect targetting to lysosomes.
	Obermuller S, Kiecke C, von Figura K, Honing S.
	J Cell Sci 115(Pt 1):185-94. 2002
3	ACP2
	Human lysosomal acid phosphatase : cloning, expression and chromosomal assignment.
	Pohlmann R, et al.
	EMBO J 7 : 2343-2350. 1988
4	ACP2
	Regional mapping of the gene for human lysosomal acid phosphatase (ACP-2) using a hybrid clone panel containing segments of human chromosome 11.
	Jones C, et al.
	Hum Genet 45 : 1-10. 1978
5	ACP2
	Regional assignments of the genes for fumarate hydratase and guanylate kinase on chromosome 1 and for lysosomal acid phosphatase and esterase A4 on chromosome 11.
	Busby N, et al.
	Cytogenet Cell Genet 16 : 105-107. 1976
6	ACP2
	Human acid phosphatase in somatic cell hybrids.
	Bruns G, et al.
	Science 184 : 480-481. 1974
7	ACP2
	Deficiency of lysosomal acid phosphatase. A new familial metabolic disorder.
	Nadler HL, et al.
	N Engl J Med 282 : 303-370. 1970